- Despite initial concerns that President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to lead HHS could be negative for many healthcare sectors, Jefferies now believes it could be a potential boon for Doximity (New York Stock Exchange: DOCUMENTS).
- Analyst Glen Santangelo